Federal Register / Vol. 66, No. 90 / Wednesday, May 9, 2001 / Notices 23721

Place: National Cancer Institute, 9000

Rockville Pike, Building 31, C Wing, 6th

Floor, Conference Room 10, Bethesda, MD

20892.

Open: 12 p.m. to 2 p.m.

Agenda: Joint meeting of the Subcommittee

on Planning and Budget and the Ad Hoc

Subcommittee on Communications followed

by a meeting of the Subcommittee on Clinical

Investigations.

Place: National Cancer Institute, 9000

Rockville Pike, Building 31, C Wing, 6th

Floor, Conference Room 10, Bethesda, MD

20892.

Contact Person:

Ms. Cherie Nichols, Executive Secretary,

Subcommittee on Planning and Budget,

(301) 496–5515.

Dr. Susan Sieber, Executive Secretary, Ad

Hoc Subcommittee on Communications

(301) 496–5946.

Dr. Ellen Feigal, Executive Secretary,

Subcommittee On Clinical Investigations,

(301) 496–6711.

Name of Committee: National Cancer

Advisory Board.

Open: May 22, 2001, 2 p.m. to 4 p.m.

Agenda: Program reports and

presentations; Business of the board.

Place: National Cancer Institute, 9000

Rockville Pike, Building 31, C Wing, 6th

Floor, Conference Room 10, Bethesda, MD

20892.

Name of Committee: National Cancer

Advisory Board.

Closed: May 22, 2001, 4 p.m. to

Adjournment.

Agenda: Review of grant applications;

Discussion of confidential personnel issues.

Place: National Cancer Institute, 9000

Rockville Pike, Building 31, C Wing, 6th

Floor, Conference Room 10, Bethesda, MD

20892.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, 8th Floor, Room 8001,

Bethesda, MD 29892–8327, (301) 496–5147.

This meeting is being published less than

15 days prior to the meeting due to

scheduling conflicts. Any interested person

may file written comments with the

committee by forwarding the statement to the

Contact Person listed on this notice. The

statement should include the name, address,

telephone number and when applicable, the

business or professional affiliation of the

interested person.

Information is also available on the

Institute’s/Center’s home page:

deainfo.nci.nih.gov/advisory/ncab.htm,

where an agenda and any additional

information for the meeting will be posted

when available.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 1, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–11601 Filed 5–8–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Amended Notice of Meeting

Notice is hereby given of a change in

the meeting of the National Advisory

Council on Drug Abuse, May 16, 2001,

1 p.m. to May 17, 2001, 4:30 p.m.,

Neuroscience Center, National Institutes

of Health, 6001 Executive Blvd.,

Rockville, MD, 20852 which was

published in the Federal Register on

April 5, 2001, Volume 66 FR 18103.

The time of the meeting for the open

session has been changed to 9 a.m. to 11

a.m. on May 17, 2001. The time of the

closed session will remain the same,

from 1 p.m. to 4:30 p.m. on May 16,

2001. The meeting is partially closed to

the public.

Dated: May 1, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–11596 Filed 5–8–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 14, 2001.

Time: 3 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Gloria B. Levin, Ph.D.,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3166,

MSC 7848, Bethesda, MD 20892, (301) 435-

1017, leving@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.305, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: May 1, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–11597 Filed 5–8–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 2, 2001.

Time: 10 a.m. to 11 a.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Russell T. Dowell, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4118,

MSC 7818, Bethesda, MD 20892, (301) 435–

1169, dowellr@drg.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.